OncologyTube Professional - Patients Click Here
62,067 video views
Loading........
Description: The basic biological processes disrupted in mesothelioma that could be utilized for targeting in the clinic. Marc Ladanyi elaborates on genetic alterations research efforts and genomic technologies th...
03:56
The basic biological processes disrupted in mesothelioma that could be utilized for targeting in the clinic. Marc Ladanyi elaborates on genetic alterations research efforts and genomic technologies that could lead to advances in the treatment of this disease. http://www.e... Video produced b...
by:ESMO | 449 views
03:56
Christian Rolfo discusses opportunities from local therapies in oncogenic driven subtypes of NSCLC. In particular, Christian Rolfo elaborates brain metastases practice management scenario with targeted therapies and combination with other treatment modalities. http://www.e... Video produced by the European Society for Medical Oncology (ESMO...
by:ESMO | 394 views
03:56
Oliver Gautschi explains the results of the EURAF study in lung cancer patients. A small population of BRAF mutated lung adenocarcinoma, activating and non-activating BRAF mutations and opportunities with BRAF inhibition drawn from the experiences in melanoma treatment. http://www.e... Video produced by the European Society for Medical Onco...
by:ESMO | 867 views
04:40
Sherene Loi and Peter Dubsky dissect the results of the national SAFIR-02 study using whole-genome cancer testing for clinical decision-making and highlight implications for clinical practice. These study was presented during ESMO 2012, the Congress of the European Society for Medical Oncology. Read...
by:ESMO | 1647 views
05:24
Christoph Zielinski discusses the latest advances in cancer research and points out the need for a more balanced distribution of medical progress, beyond economic barriers. This interview was recorded during ESMO 2012, the Congress of the European Society for Medical Oncology. Read all the news abou...
by:ESMO | 1580 views
03:20
Jean-Yves Blay explains the results of a large trial in sarcoma and helps us understand what we should learn for future treatment of these patients. This study was presented during ESMO 2012, the Congress of the European Society for Medical Oncology. Read all the news about the latest in cancer and ...
by:ESMO | 1722 views
03:50
Cora Sternberg describes an interesting phase III study confirming the positive results for a new drug in RCC treatment. This study was presented during ESMO 2012, the Congress of the European Society for Medical Oncology. Read all the news about the latest in cancer and oncology from the Congress h...
by:ESMO | 1937 views
02:37
Sandra Swain compares results of the PHARE and the HERA trials about the optimal duration of trastuzumab for HER2-positive early breast cancer and draws important conclusions for patients. These studies were presented during ESMO 2012, the Congress of the European Society for Medical Oncology. Read ...
by:ESMO | 1958 views
05:22
Martine Piccart, ESMO President, calls for more international collaboration to make personalized medicine a reality as soon as possible. This video was recorded during ESMO 2012, the Congress of the European Society for Medical Oncology. Read all the news about the latest in cancer and oncology from...
by:ESMO | 2790 views
00:52
Prof Vera Hirsh on Lux Lung 3 study at ESMO 2012
by:ESMO | 2456 views

About ESMO
Description: ESMO official video channel: http://www.youtube.com/esmochannel Access all our scientific video resources!

Company: The European Society for Medical Oncology (ESMO) is the leading European professional medical oncology organisation comprising a network of more than 10,000 oncology professionals in over 100 countries. At ESMO we constantly strive to address the issues that affect both you as an individual and the oncology profession as a whole. Our objective is to advance and promote the specialty of medical oncology, provide post-graduate education and training for medical oncologists and establish platforms for the dissemination and sharing of knowledge. We promote a multidisciplinary approach to cancer treatment, in our goal to prevent cancer and ensure optimal treatment for all cancer patients.
Links
Channel Url:

Website:


Social Links: